Imagen de Portada

A Saddlepoint Framework for Accurate Inference in Multicenter Clinical Trials With Imbalanced Clusters

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autor principal:	Haidy A. Newer
Formato:	Artículo Open Access
Publicado:	Wiley 2026
Materias:	Statistics in Medicine
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Preference‐Informed Cluster Randomized Design for Pragmatic Clinical Trials
por: Yuwei Cheng, et al.
Publicado: (2026)

Clinical Trial Simulation: Planning With the OCTAVE Framework, Implementation and Validation Principles
por: Kim May Lee, et al.
Publicado: (2026)

Futility Monitoring in Clinical Trials
por: Ana M. Ortega‐Villa, et al.
Publicado: (2025)

Handling Missing Outcome Data in Cluster Randomized Trials With Both Individual‐ and Cluster‐Level Dropout
por: Analissa Avila, et al.
Publicado: (2025)

Model‐Robust Standardization in Cluster‐Randomized Trials
por: Fan Li, et al.
Publicado: (2025)

Correction to “Model‐Robust Standardization in Cluster‐Randomized Trials”
Publicado: (2026)

On Anticipation Effect in Stepped Wedge Cluster Randomized Trials
por: Hao Wang, et al.
Publicado: (2026)

Bayesian Response‐Adaptive Randomization for Cluster Randomized Controlled Trials
por: Yunyi Liu, et al.
Publicado: (2026)

An Empirical Assessment of the Cost of Dichotomization of the Outcome of Clinical Trials
por: Erik W. van Zwet, et al.
Publicado: (2026)

Patient‐Centric Pragmatic Clinical Trials: Opening the DOOR
por: Scott R. Evans, et al.
Publicado: (2026)

Testing for Similarity of Dose Response in Multiregional Clinical Trials
por: Holger Dette, et al.
Publicado: (2025)

RMST for Interval‐Censored Data in Oncology Clinical Trials
por: Xiyuan Gao, et al.
Publicado: (2025)

A Biomarker Signature‐Guided Clinical Trial Design for Precision Medicine
por: Yuan Li, et al.
Publicado: (2025)

Analysis of Stepped‐Wedge Cluster Randomized Trials: A Tutorial Using Marginal Models
por: Elizabeth L. Turner, et al.
Publicado: (2026)

Bayesian Ordered Lattice Design for Phase I Clinical Trials
por: Gi‐Ming Wang, et al.
Publicado: (2026)

Adaptive Biomarker‐Based Design for Early Phase Clinical Trials
por: Alessandra Serra, et al.
Publicado: (2025)

Response‐Adaptive Randomization Procedure in Clinical Trials with Surrogate Endpoints
por: Jingya Gao, et al.
Publicado: (2024)

Designing Stepped Wedge Cluster Randomized Trials With a Baseline Measurement of the Outcome
por: Kendra Davis‐Plourde, et al.
Publicado: (2025)

Cluster‐Level Analyses to Estimate a Risk Difference in a Cluster Randomized Trial With Confounding Individual‐Level Covariates: A Simulation Study
por: Jules Antoine Pereira Macedo, et al.
Publicado: (2025)

Using Propensity Score Weighting With Clustered Data When the Treatment Is Applied at the Level of the Cluster and Outcomes Are Assessed at the Level of the Individual: The Observational Analog of Cluster Randomization Trials
por: Peter C. Austin
Publicado: (2026)

A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
por: Moka Komaki, et al.
Publicado: (2026)

On Inclusion of Covariates in Model Based Dose Finding Clinical Trial Designs
por: Adrien Ollier, et al.
Publicado: (2025)

Modern Causal Inference Approaches to Improve Power for Subgroup Analysis in Randomized Controlled Trials
por: Antonio D'Alessandro, et al.
Publicado: (2026)

Probabilistic Clustering Using Multivariate Growth Mixture Model in Clinical Settings—A Scleroderma Example
por: Ji Soo Kim, et al.
Publicado: (2026)

Sequential Monitoring of Covariate‐Adaptive Randomized Clinical Trials With Non‐Parametric Approaches
por: Xiaotian Chen, et al.
Publicado: (2025)

Doubly Robust Estimators of the Restricted Mean Time in Favor Estimands in Individual‐ and Cluster‐Randomized Trials
por: Xi Fang, et al.
Publicado: (2026)

Time‐Varying Treatment Effect Models in Stepped‐Wedge Cluster‐Randomized Trials With Multiple Interventions
por: Zhe Chen, et al.
Publicado: (2026)

Analysis of Cohort Stepped Wedge Cluster‐Randomized Trials With Nonignorable Dropout via Joint Modeling
por: Alessandro Gasparini, et al.
Publicado: (2025)

Exact Randomized Two‐Stage Phase 2 Clinical Trial Designs for Two Binary Co‐Primary Endpoints
por: Hyejung Jung, et al.
Publicado: (2026)

Accounting for Carryover Toxicity in Phase I Clinical Trials with Intra‐Patient Dose Escalation
por: Chloe E. Falke, et al.
Publicado: (2025)

A General Framework for Designing and Evaluating Active‐Controlled Trials with Non‐Inferiority Objectives
por: Antonio Olivas‐Martinez, et al.
Publicado: (2026)

Dynamic Borrowing From Historical Controls via the Synthetic Prior With Covariates in Randomized Clinical Trials
por: Daniel E. Schwartz, et al.
Publicado: (2026)

Synergy Area With FDR ‐Controlled Evaluation ( SAFE ) to Robustly Assess Safety Profile in Clinical Trials
por: Tianyu Zhan, et al.
Publicado: (2026)

Matching‐Assisted Power Prior for Incorporating Real‐World Data in Randomized Clinical Trial Analysis
por: Ruoyuan Qian, et al.
Publicado: (2025)

Doubly Robust Estimation and Sensitivity Analysis With Outcomes Truncated by Death in Multi‐Arm Clinical Trials
por: Jiaqi Tong, et al.
Publicado: (2025)

A Framework for Generating Realistic Synthetic Tabular Data in a Randomized Controlled Trial Setting
por: Niki Z. Petrakos, et al.
Publicado: (2025)

Reinforced Borrowing Framework: Leveraging Auxiliary Data for Individualized Inference
por: Ziyu Ji, et al.
Publicado: (2024)

An Integrated and Coherent Framework for Point Estimation and Hypothesis Testing With Concurrent Controls in Platform Trials
por: Tianyu Zhan, et al.
Publicado: (2025)

A Unified Framework for Statistical Inference and Power Analysis of Single and Comparative Fβ Scores
por: Chih‐Yuan Hsu, et al.
Publicado: (2026)

The Harms of Class Imbalance Corrections for Machine Learning Based Prediction Models: A Simulation Study
por: Alex Carriero, et al.
Publicado: (2025)